98%
921
2 minutes
20
Aim: Preventing frailty is crucial; however, the current evidence is limited to findings from older adults and may not apply to earlier life stages. This study examined the associations between health screening findings, body mass index, lifestyle factors, and medical findings in midlife with frailty in older ages by longitudinal analysis and the associations between them in older ages by cross-sectional analysis.
Methods: The study was conducted in a population-based cohort of the Circulatory Risk in Communities Study. We used the data of 1785 men and women aged 40-65 years (mean age: 54 years) who underwent health examinations between 2002 and 2004 in two Japanese communities. Among them, the frailty evaluation was conducted for 784 men and women aged 60 years or older (average age: 69 years) between 2017 and 2019. Multinomial logistic regression analysis was performed to calculate the multivariable odds ratios of pre-frailty and frailty compared with non-frailty, based on body mass index, lifestyle factors, and medical findings in midlife using longitudinal data, and based on these factors in older ages using cross-sectional data.
Results: We identified 351 non-frailty, 400 pre-frailty, and 33 frailty cases according to Fried's phenotype. Being overweight in middle age was associated with frailty in older ages in the longitudinal analysis, while being overweight in older ages was not in the cross-sectional analysis. A history of musculoskeletal disorders in both midlife and older ages was associated with frailty. In the cross-sectional analysis but not in the longitudinal analysis, the factors associated with pre-frailty or frailty included current smoking, current drinking, exercise, consumption of vegetables and soy products, and diabetes mellitus.
Conclusions: Being overweight in midlife was associated with frailty in older ages, pointing to the importance of keeping an appropriate weight and lifestyle modifications in midlife to prevent frailty. Geriatr Gerontol Int 2025; 25: 889-896.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12238809 | PMC |
http://dx.doi.org/10.1111/ggi.70074 | DOI Listing |
Pharmacoecon Open
September 2025
Department of Pharmacy, The Second Affiliated Hospital of Army Medical University, No.83 Xinqiao Central Street, Shapingba District, Chongqing, 400037, China.
Objective: Two vaccines against herpes zoster (HZ) are currently authorized for use in China: the adjuvanted recombinant zoster vaccine (RZV) and live-attenuated Zoster Vaccine Live (ZVL). The significant disparities in prices and efficacy between the two vaccines necessitate an evaluation of their relative value in order to make an informed choice. This study aimed to evaluate the comparative cost effectiveness of RZV, ZVL, and no vaccination for older adults at different ages from the societal perspective.
View Article and Find Full Text PDFCancer
September 2025
Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York, USA.
Background: Trials of neoadjuvant chemoimmunotherapy (chemoIO) have changed the standard of care for resectable nonsmall cell lung cancer (NSCLC). This study characterizes the outcomes of off-trial patients who received treatment with neoadjuvant chemoIO.
Methods: The authors analyzed records of patients with stage IB-III NSCLC who received neoadjuvant chemoIO with an intent to proceed to surgical resection at three US academic institutions.
JAACAP Open
September 2025
Kennedy Krieger Institute, Baltimore, Maryland.
Objective: To identify correlates of deliberate self-harm (DSH) in youth with autism and/or intellectual disability (ID).
Method: This retrospective longitudinal cohort analysis used claims data for youth ages 5 to 24 years continuously enrolled in Medicaid in a midwestern state for 6 months and diagnosed with autism and/or ID between 2010 and 2020 (N = 41,230). Cox proportional hazards regression examined associations between demographic and clinical variables and time to DSH for study cohorts with autism and/or ID.